Table 2.
Arterial Territory | Type V Atheroma Plaque |
Linear Calcification |
Medial Calcification |
No Calcification |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dialysis |
Control | Dialysis |
Control | Dialysis |
Control | Dialysis |
Control | |||||
CVD | No CVD | CVD | No CVD | CVD | No CVD | CVD | No CVD | |||||
Carotid | 32 (34)c | 37 (26) | 9 (4.5)a | 49 (52)c | 58 (42)b | 28 (13)a | 12 (12) | 10 (7) | 4 (1.9)a | 7 (7) | 27 (19) | 161 (79.7)a |
Femoral | 17 (18)c | 15 (10) | NA | 60 (63)c | 61 (44) | NA | 10 (10) | 8 (5) | NA | 14 (14) | 16 (11) | NA |
Brachial | 0 | 0 | NA | 7 (7) | 7 (5) | NA | 1 (1) | 1 (0.7) | NA | 80 (85) | 89 (66) | NA |
Sample size and (percentages) are shown. Percentages in dialysis patients are taken from the total number of patients in each subgroup (CVD [n = 94] versus no CVD [n = 138]). Because of anatomic particularities, we obtained valuable images from 202 of 208 control participants. Similarly, we obtained femoral exams in 201 and brachial exams in 185 dialysis patients.
P < 0.05 when comparing dialysis with controls.
P < 0.05 when separately comparing different types of VC in dialysis and controls.
P < 0.05 when comparing CVD versus no CVD groups in dialysis patients.